Clarivate Plc has released its 2024 Drugs to Watch report, highlighting 13 potential therapeutics believed to transform healthcare in the following year. The drugs cover a variety of conditions, from sickle cell anemia to AMD. The report also emphasizes the growing influence of technologies such as CRISPR-Cas9 gene editing and AI/ML in drug development, potentially expediting innovation and the delivery of life-saving therapies.

DeepSeek iOS app sends data unencrypted to ByteDance-controlled servers
DeepSeek, an app by ByteDance, sends data, including encrypted information, to servers located in China, leading to concerns over privacy breaches. After security firm Wiz